AA
PROK icon

Ancora Advisors’s ProKidney PROK Stock Holding History

Ancora Advisors’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,333
Closed -$23K – 2309
2022
Q1 		$23K Hold
2,333
– – ﹤0.01% 1511
2021
Q4 		$23K Hold
2,333
– – ﹤0.01% 1539
2021
Q3 		$23K Buy
+2,333
New +$23K ﹤0.01% 1436

Other funds holding PROK

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Ancora Advisors's PROK Position: Q2 2022 in Review

Ancora Advisors sold out of ProKidney (PROK) in Q2 2022, closing a stake of 2,333 shares — an estimated $23K sold.

Ancora Advisors first reported a position in PROK in Q3 2021 and held it in 3 quarters. The position peaked at $23K in Q1 2022. 67 funds tracked by Wall St. Rank hold PROK as of Q2 2022.

  • Ancora Advisors reported no remaining ProKidney position as of Q2 2022 after selling out during the quarter.
  • Ancora Advisors sold 2,333 ProKidney shares in Q2 2022, an estimated $23K.
  • Ancora Advisors first reported a position in ProKidney in Q3 2021 and held it in 3 quarters.
  • Ancora Advisors's ProKidney position peaked at $23K in Q1 2022.
  • 67 funds tracked by Wall St. Rank held ProKidney as of Q2 2022.

Based on Ancora Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.